Latest News

Repurposing FDA-approved drugs can help fight back breast cancer




Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease. Led by researchers at Baylor College of Medicine and the National Taiwan University College of Medicine, the team shows in the journal Scientific Reports proof of concept that this approach can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.

Source link





Related posts

Medical News Today: What causes acid reflux and shortness of breath?

Newsemia

Vitamin B supplements may protect kidney function in children with diabetes

Newsemia

Nicoya gains series A funding for digital drug discovery program

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy